Literature DB >> 28287111

Glomerular disease: A suPAR kidney connection found in the bone marrow.

Lorenzo Gallon1, Susan E Quaggin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28287111      PMCID： PMC6450403          DOI： 10.1038/nrneph.2017.29

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Resolution of recurrent focal segmental glomerulosclerosis after retransplantation.

Authors:  Lorenzo Gallon; Joseph Leventhal; Anton Skaro; Yashpal Kanwar; Antonio Alvarado
Journal:  N Engl J Med       Date:  2012-04-26       Impact factor: 91.245

2.  The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis.

Authors:  Björn Meijers; Rutger J H Maas; Ben Sprangers; Kathleen Claes; Ruben Poesen; Bert Bammens; Maarten Naesens; Jeroen K J Deegens; Ruth Dietrich; Markus Storr; Jack F M Wetzels; Pieter Evenepoel; Dirk Kuypers
Journal:  Kidney Int       Date:  2014-01-08       Impact factor: 10.612

3.  Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report.

Authors:  Margret E Bock; Heather E Price; Lorenzo Gallon; Craig B Langman
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 8.237

4.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Authors:  Changli Wei; Shafic El Hindi; Jing Li; Alessia Fornoni; Nelson Goes; Junichiro Sageshima; Dony Maiguel; S Ananth Karumanchi; Hui-Kim Yap; Moin Saleem; Qingyin Zhang; Boris Nikolic; Abanti Chaudhuri; Pirouz Daftarian; Eduardo Salido; Armando Torres; Moro Salifu; Minnie M Sarwal; Franz Schaefer; Christian Morath; Vedat Schwenger; Martin Zeier; Vineet Gupta; David Roth; Maria Pia Rastaldi; George Burke; Phillip Ruiz; Jochen Reiser
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

5.  Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice.

Authors:  Dominique Cathelin; Sandrine Placier; Michael Ploug; Marie-Christine Verpont; Sophie Vandermeersch; Yosu Luque; Alexandre Hertig; Eric Rondeau; Laurent Mesnard
Journal:  J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 10.121

Review 6.  Causes and pathogenesis of focal segmental glomerulosclerosis.

Authors:  Agnes B Fogo
Journal:  Nat Rev Nephrol       Date:  2014-12-02       Impact factor: 28.314

7.  Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.

Authors:  Aditi Sinha; Jaya Bajpai; Savita Saini; Divya Bhatia; Aarti Gupta; Mamta Puraswani; Amit K Dinda; Sanjay K Agarwal; Shailaja Sopory; Ravindra M Pandey; Pankaj Hari; Arvind Bagga
Journal:  Kidney Int       Date:  2014-01-15       Impact factor: 10.612

8.  Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.

Authors:  V J Savin; R Sharma; M Sharma; E T McCarthy; S K Swan; E Ellis; H Lovell; B Warady; S Gunwar; A M Chonko; M Artero; F Vincenti
Journal:  N Engl J Med       Date:  1996-04-04       Impact factor: 91.245

9.  Soluble Urokinase Receptor and Chronic Kidney Disease.

Authors:  Salim S Hayek; Sanja Sever; Yi-An Ko; Howard Trachtman; Mosaab Awad; Shikha Wadhwani; Mehmet M Altintas; Changli Wei; Anna L Hotton; Audrey L French; Laurence S Sperling; Stamatios Lerakis; Arshed A Quyyumi; Jochen Reiser
Journal:  N Engl J Med       Date:  2015-11-05       Impact factor: 91.245

10.  Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease.

Authors:  Eunsil Hahm; Changli Wei; Isabel Fernandez; Jing Li; Nicholas J Tardi; Melissa Tracy; Shikha Wadhwani; Yanxia Cao; Vasil Peev; Andrew Zloza; Jevgenijs Lusciks; Salim S Hayek; Christopher O'Connor; Markus Bitzer; Vineet Gupta; Sanja Sever; David B Sykes; David T Scadden; Jochen Reiser
Journal:  Nat Med       Date:  2016-12-12       Impact factor: 53.440
  10 in total
  3 in total

1.  Experimental concerns regarding suPAR-related proteinuria.

Authors:  Laurent Mesnard; Yosu Luque; Eric Rondeau
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

2.  SuPAR and FSGS: is the jury still out?

Authors:  Lorenzo Gallon; Susan E Quaggin
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

3.  Development of membranoproliferative glomerulonephritis-like glomerulopathy in a patient with neutrophilia resulting from endogenous granulocyte-colony stimulating factor overproduction: a case report.

Authors:  Seigo Ito; Takahiro Uchida; Naoki Oshima; Takashi Oda; Hiroo Kumagai
Journal:  BMC Nephrol       Date:  2018-10-04       Impact factor: 2.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.